Jounce Therapeutics, Inc.
JNCEDelisted May 4, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001640455
Jounce Therapeutics, Inc. was delisted on May 4, 2023; its insiders filed their last Form 4 on May 5, 2023; 84 institutions reported holding it in 13F filings for Q1 2023, worth $64.1M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Jounce Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 113 | 3 | 102 | −8 |
| Shares | 42.3M | 54.6K | 42.7M | +428.2K (+1.0%) |
| Value | $287.1M | $370.0K | $129.3M | −$157.4M (−54.9%) |
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Jounce Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 82,739 | $251.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 52,462 | $159.0K | 0.00% |
| Walleye Capital LLC | 52,427 | $159.0K | 0.00% |
| Cornercap Investment Counsel Inc | 42,065 | $127.0K | 0.02% |
| Susquehanna International Group, LLP | 41,255 | $125.0K | 0.00% |
| Marshall Wace, LLP | 39,339 | $119.0K | 0.00% |
| XTX Topco Ltd | 37,362 | $113.0K | 0.05% |
| Jump Financial, LLC | 36,500 | $111.0K | 0.00% |
| Algert Global LLC | 33,430 | $101.0K | 0.01% |
| HRT Financial LP | 20,010 | $60.0K | 0.00% |
| Dynamic Technology Lab Private Ltd | 18,376 | $56.0K | 0.01% |
| SG Americas Securities, LLC | 15,768 | $48.0K | 0.00% |
| Bender Robert & Associates | 10,000 | $30.0K | 0.01% |
| Point72 Hong Kong Ltd | 2,190 | $7.00K | 0.00% |
| Credit Suisse AG | 39 | $0 | 0.00% |
Sold out (23)
Institutions that held Jounce Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Logos Global Management LP | 1,400,000 | $9.51M |
| Acuta Capital Partners, LLC | 813,500 | $5.52M |
| Silverarc Capital Management, LLC | 248,347 | $1.69M |
| BVF Inc | 126,797 | $861.0K |
| Putnam Investments LLC | 51,120 | $347.0K |
| Ziegler Capital Management, LLC | 50,946 | $346.0K |
| Prudential Financial Inc | 34,645 | $235.0K |
| Bessemer Group Inc | 27,585 | $187.0K |
| State of Wisconsin Investment Board | 24,900 | $169.0K |
| Trexquant Investment LP | 19,503 | $132.0K |
| Manufacturers Life Insurance Company, The | 15,379 | $104.4K |
| Prelude Capital Management, LLC | 14,800 | $100.0K |
| ExodusPoint Capital Management, LP | 11,964 | $81.0K |
| ProShare Advisors LLC | 11,484 | $78.0K |
| UNC Management Company, Inc. | 8,115 | $55.0K |
| State of Wyoming | 6,229 | $42.0K |
| Group One Trading, L.P. | 2,250 | $15.0K |
| Russell Investments Group, Ltd. | 2,017 | $13.0K |
| Bollard Group LLC | 1,009 | $7.00K |
| Koshinski Asset Management, Inc. | 300 | $2.04K |
| Simplex Trading, LLC | 287 | $1.00K |
| Mass General Brigham, Inc | 20,957 | $1.00K |
| Toronto Dominion Bank | 4 | $0 |
Not filed for Q2 2022 yet (3)
Institutions that held Jounce Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Susquehanna Fundamental Investments, LLC | 35,698 | $242.0K |
| Parametric Portfolio Associates LLC | 14,942 | $101.0K |
| Amalgamated Financial Corp. | 3,986 | $27.0K |